Biocon and Mylan announce positive CHMP opinion for Fulphila, Biosimilar Pegfilgrastim
Fulphila was approved by the US FDA earlier this year and is the first FDA-approved biosimilar for Neulasta in the US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Centaur Pharma concludes 10th common cold awareness week campaign
Centaur has been undertaking the 'Common Cold Awareness Week' campaign to prevent people from self medication and encourage them…
Sun Pharma gets Australia TGA nod for plaque psoriasis treatment drug
Sun Pharma is to launch a patient support programme to assist patients prescribed with this drug
Schott Kaisha hosts pharma packaging stalwarts at its Jambusar plant, Gujarat
More than 60 delegates took part in the half-day visit to Schott Kaisha’s state-of-the-art facility
GSK grabs new drug development head from Boehringer
GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim
AstraZeneca plots China robot offensive to counter price cuts
With smart cancer diagnostics and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move…
Glenmark Pharma inducted into Dow Jones Sustainability Indices
The evaluation included 24 long-term economic, environmental and social criteria
NCRM signs pact with GNC, Japan
GN Corporation Co was granted the license to host the International Stem Cells & Regenerative Medicine meet
Lupin appoints Alok Sonig as CEO – US Generics and Global Head –Generics R&D & Biosimilars
He will also be responsible for Lupin’s global Biosimilars business
Sun Pharma bags receipt of European Commission approval
The drug ILUMETRI (tildrakizumab) is indicated for the treatment of adults with moderate-to-severe chronic plaque psoriasis
Sun…
Alembic Pharma gets USFDA nod for depressive disorder drug
The company has received approval from the USFDA to market its product which is a generic equivalent of Wyeth Pharma Inc's Pristiq…
Aurobindo Pharma gets nod from South African health authority for HIV drug
The approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of…
Romaco Pharmatechnik appoints Markus Regner as new MD
Markus Regner takes over at the Karlsruhe facility in Germany
SC allows sale of Saridon, three other drugs
The top court, however, did not grant any relief to the other medicines falling in the list of 328 FDC drugs which were banned by…
DoP urges pharma industry to develop innovative drugs
Pharmexcil organises seminar on Financial Schemes for Pharma industry and Outstanding Export Performance Awards at its 14 th…
Lupin appoints Dr Kamal K Sharma as Advisor
Dr Sharma has vast industry experience spanning over four decades
Lupin announced the appointment of Dr Kamal K Sharma as Advisor…
Alembic Pharma gets US FDA nod for diabetes drug
The company's product is a generic version of Takeda Pharma USA's Kazano tablets
Glenmark Pharma gets final US FDA nod for menopause symptom relief drug
The approved product is a generic version of Novo Nordisk's VAGIFEM
Aspirin does not reduce heart attack, stroke risk: Study
Three studies were conducted and the report was published in New England Journal of Medicine
Lupin’s Nagpur facility inspection concludes with no observation
This inspection was a product specific pre-approval inspection